3,5-Dichloro-N-[[(1',5',6-exo,6')-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]benzamide

CAS : 1346233-68-8

Ref. 3D-FD177123

Informations sur le produit

• Nom: 3,5-Dichloro-N-[[(1',5',6-exo,6')-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]benzamide
• CAS: 1346233-68-8

Description

3,5-Dichloro-N-[[(1',5',6-exo,6')-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]benzamide is a drug that binds to calcium and chondroitin sulfate in the extracellular environment of cancer cells. 3,5-Dichloro-N-[(1',5',6'-exo,6')-(3,3'-dimethylbutyl)-3'-azabicyclo[3.1.0]hexane]-2,2'-dicarboxylic acid (DCA) has been shown to selectively kill brain tumor cells over normal brain cells in vitro by inhibiting protein synthesis and inducing cell death through a multistep process. DCA also inhibits the production of antigens that are involved in the interaction between T lymph

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 369.33 g/mol
• Formule: C₁₉H₂₆Cl₂N₂O
• Degré de pureté: Min. 95%